Jomed To Begin Anastomosis Device Clinicals In Second Quarter 2000
This article was originally published in The Gray Sheet
Executive Summary
Swedish-based stent manufacturer Jomed is looking to start European clinical studies for a sutureless graft connector anastomosis system by the second quarter of 2000, the company said, in the wake of promising six-month animal data.
You may also be interested in...
Guidant's CTS Buy Provides Platform For Growth In Cardiac Surgery Market
Guidant's planned acquisition of minimally invasive cardiac surgery device maker CardioThoracic Systems for $313 mil. in stock provides greater access to cardiac surgeons as well as a platform for growth in the cardiac surgery market.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.